BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34894456)

  • 1. A risk prediction model for selecting high-risk population for computed tomography lung cancer screening in China.
    Guo LW; Lyu ZY; Meng QC; Zheng LY; Chen Q; Liu Y; Xu HF; Kang RH; Zhang LY; Cao XQ; Liu SZ; Sun XB; Zhang JG; Zhang SK
    Lung Cancer; 2022 Jan; 163():27-34. PubMed ID: 34894456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese population.
    Lyu Z; Li N; Chen S; Wang G; Tan F; Feng X; Li X; Wen Y; Yang Z; Wang Y; Li J; Chen H; Lin C; Ren J; Shi J; Wu S; Dai M; He J
    Cancer Med; 2020 Jun; 9(11):3983-3994. PubMed ID: 32253829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Compliance of lung cancer screening with low-dose computed tomography and influencing factors in urban area of Henan province].
    Guo LW; Zhang SK; Liu SZ; Yang FN; Wu Y; Zheng LY; Chen Q; Cao XQ; Sun XB; Zhang JG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):1076-1080. PubMed ID: 32741174
    [No Abstract]   [Full Text] [Related]  

  • 4. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
    Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
    Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China].
    Wen Y; Yu LZ; Du LB; Wei DH; Liu YY; Yang ZY; Zheng YD; Wu Z; Yu XY; Zhao L; Yu YW; Chen HD; Ren JS; Qin C; Xu YJ; Cao W; Wang F; Li J; Tan FW; Dai M; Chen WQ; Li N; He J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 May; 55(5):633-639. PubMed ID: 34034404
    [No Abstract]   [Full Text] [Related]  

  • 6. Special issue "The advance of solid tumor research in China": Participants with a family history of cancer have a higher participation rate in low-dose computed tomography for lung cancer screening.
    Guo LW; Meng QC; Zheng LY; Chen Q; Liu Y; Xu HF; Kang RH; Zhang LY; Liu SZ; Sun XB; Zhang SK
    Int J Cancer; 2023 Jan; 152(1):7-14. PubMed ID: 35362560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the efficacy of lung cancer screening in urban areas of Henan Province by low-dose computed tomography from 2013 to 2017].
    Guo LW; Liu SZ; Zhang SK; Yang FN; Wu Y; Zheng LY; Chen Q; Cao XQ; Sun XB
    Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):155-159. PubMed ID: 32135652
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lung cancer screening in urban Beijing from 2014 to 2019].
    Yang L; Zhang X; Liu S; Li HC; Li QY; Wang N; Ji JF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Mar; 55(3):339-345. PubMed ID: 33730825
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China.
    Guo LW; Chen Q; Shen YC; Meng QC; Zheng LY; Wu Y; Cao XQ; Xu HF; Liu SZ; Sun XB; Qiao YL; Zhang SK
    JAMA Netw Open; 2020 Nov; 3(11):e2019039. PubMed ID: 33141158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study.
    Zhu J; Wang L; Gong W; Li X; Wang Y; Zhu C; Li H; Shi L; Yang C; Du L
    Cancer; 2024 Apr; 130(S8):1403-1414. PubMed ID: 37916832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
    Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
    EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for lung cancer based on low-dose computed tomography screening].
    Jin YJ; Tang W; Huang Y; Wang JW; Hou DH; Qi LL; Zhao SJ; Wu N
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):222-227. PubMed ID: 32252201
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of a single low-dose computed tomography screening for lung cancer: A population-based perspective cohort study in China.
    Yu Z; Ni P; Yu H; Zuo T; Liu Y; Wang D
    Int J Cancer; 2024 Feb; 154(4):659-669. PubMed ID: 37819155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [China National Lung Cancer Screening Guideline with Low-dose Computed 
Tomography (2018 version)].
    Zhou Q; Fan Y; Wang Y; Qiao Y; Wang G; Huang Y; Wang X; Wu N; Zhang G; Zheng X; Bu H; Li Y; Wei S; Chen L; Hu C; Shi Y; Sun Y
    Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):67-75. PubMed ID: 29526173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.
    Tammemagi CM; Pinsky PF; Caporaso NE; Kvale PA; Hocking WG; Church TR; Riley TL; Commins J; Oken MM; Berg CD; Prorok PC
    J Natl Cancer Inst; 2011 Jul; 103(13):1058-68. PubMed ID: 21606442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic lung cancer screening with low-dose computed tomography in National Cancer Center of China: The first 14 years' experience.
    Tang W; Liu L; Huang Y; Zhao S; Wang J; Liang M; Jin Y; Zhou L; Liu Y; Tang Y; Xu Z; Zhang K; Tan F; Bi N; Wang Z; Wang F; Li N; Wu N
    Cancer Med; 2024 Feb; 13(3):e6914. PubMed ID: 38234199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in lung cancer risk among smokers.
    Bach PB; Kattan MW; Thornquist MD; Kris MG; Tate RC; Barnett MJ; Hsieh LJ; Begg CB
    J Natl Cancer Inst; 2003 Mar; 95(6):470-8. PubMed ID: 12644540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
    Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK
    Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
    Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
    Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.